Anticancer drugs: Antipsychotic to anticancer agent?

Comment

Darren J Burgess. Nat Rev Drug Discov. 2012.

. 2012 Jun 29;11(7):516.

doi: 10.1038/nrd3783.

No abstract available

Comment on

Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells.
Sachlos E, Risueño RM, Laronde S, Shapovalova Z, Lee JH, Russell J, Malig M, McNicol JD, Fiebig-Comyn A, Graham M, Levadoux-Martin M, Lee JB, Giacomelli AO, Hassell JA, Fischer-Russell D, Trus MR, Foley R, Leber B, Xenocostas A, Brown ED, Collins TJ, Bhatia M. Sachlos E, et al. Cell. 2012 Jun 8;149(6):1284-97. doi: 10.1016/j.cell.2012.03.049. Epub 2012 May 24. Cell. 2012. PMID: 22632761

Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data.
Cheng HW, Liang YH, Kuo YL, Chuu CP, Lin CY, Lee MH, Wu AT, Yeh CT, Chen EI, Whang-Peng J, Su CL, Huang CY. Cheng HW, et al. Cell Death Dis. 2015 May 7;6(5):e1753. doi: 10.1038/cddis.2015.77. Cell Death Dis. 2015. PMID: 25950483 Free PMC article.
[Degrading anticancer drugs in the medical environment using a visible light-driven photocatalyst].
Sato J, Kikuchi S, Kudo K. Sato J, et al. Yakugaku Zasshi. 2014;134(8):909-14. doi: 10.1248/yakushi.14-00063. Yakugaku Zasshi. 2014. PMID: 25088322 Japanese.
Stem cells. Antipsychotic to anticancer agent?
Burgess DJ. Burgess DJ. Nat Rev Cancer. 2012 Jun 22;12(7):452-3. doi: 10.1038/nrc3305. Nat Rev Cancer. 2012. PMID: 22722397
[Hepatic tolerance of atypical antipsychotic drugs].
Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora JF, Aubriot-Delmas B, Glikman J, Januel D. Dumortier G, et al. Encephale. 2002 Nov-Dec;28(6 Pt 1):542-51. Encephale. 2002. PMID: 12506267 Review. French.
Advances in the development of hybrid anticancer drugs.
Fortin S, Bérubé G. Fortin S, et al. Expert Opin Drug Discov. 2013 Aug;8(8):1029-47. doi: 10.1517/17460441.2013.798296. Epub 2013 May 7. Expert Opin Drug Discov. 2013. PMID: 23646979 Review.